Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Hans Fritz"'
Autor:
Nancy A. Nicolson, Maurice Theunissen, Soraya M.R. Jonker, Jan Schepers, Hans-Fritz Gramke, Madelon L. Peters, Marco A. E. Marcus, Rudy M.M.A. Nuijts
Publikováno v:
PLOS ONE, 13(8):0201511. Public Library of Science
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201511 (2018)
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201511 (2018)
OBJECTIVES: The primary aim of the study was to assess the convergent validity of the Surgical Fear Questionnaire (SFQ) with other self-report instruments and biological indices of stress. Secondary aims were the examination of predictors of the leve
Autor:
Audrey A.A. Fiddelers, M. Marcus, Hans-Fritz Gramke, Maurice Theunissen, Alfons G.H. Kessels, Björn Stessel, Elbert A.J. Joosten
Publikováno v:
Current Therapeutic Research, Vol 76, Iss C, Pp 120-125 (2014)
Current Therapeutic Research-Clinical and Experimental, 76, 120-125. Elsevier Science
Current Therapeutic Research, Clinical and Experimental
Current Therapeutic Research-Clinical and Experimental, 76, 120-125. Elsevier Science
Current Therapeutic Research, Clinical and Experimental
Background: Strong opioids in the home setting after ambulatory surgery have rarely been studied for fear of hazardous adverse effects such as respiratory depression. Objectives: We compared the efficacy of paracetamol/controlled-release (CR) oxycodo
Autor:
Theunissen, Maurice, Jonker, Soraya, Schepers, Jan, Nicolson, Nancy A., Nuijts, Rudy, Gramke, Hans-Fritz, Marcus, Marco A. E., Peters, Madelon L.
Publikováno v:
PLoS ONE; 8/9/2018, Vol. 13 Issue 8, p1-19, 19p
Autor:
Maria A. Juliano, Hans Fritz, Isabel de Fátima Correia Batista, Claudio A. M. Sampaio, Misako U. Sampaio, Ennes A. Auerswald, Maria Luiza Vilela Oliva, Sonia A. de Andrade
Publikováno v:
Immunopharmacology. 45:145-149
Kunitz type Bauhinia ungulata factor Xa inhibitor (BuXI) was purified from B. ungulata seeds. BuXI inactivates factor Xa and human plasma kallikrein (HuPK) with K i values of 18.4 and 6.9 nM, respectively. However, Bauhinia variegata trypsin inhibito
Publikováno v:
Immunopharmacology. 43:287-291
Bradykinin and kallidin are released during dermal injury and inflammation as a result of activation of kallikreins which cleave high- and low-molecular weight kininogen (HMW and LMW kininogen, respectively). In the skin, kinins are involved, e.g., a
Autor:
Matthias Siebeck, Hans Fritz, Michael Fautz, Eric T. Whalley, Sabine Eich-Rathfelder, Felix Hohenbleicher
Publikováno v:
Immunopharmacology. 36:173-177
Previous experiments in anesthetized pigs have demonstrated that blockade of the bradykinin B2 receptor in experimental endotoxin shock attenuates LPS-induced organ failure, lung dysfunction and mortality. Additional B1 receptor blockade in this situ
Autor:
Matthias Siebeck, Hans Fritz, M. Schorr, Bernhard Stumpf, Eric T. Whalley, Erwin Spannagl, John C. Cheronis
Publikováno v:
Immunopharmacology. 33:81-84
In order to investigate the contribution of kinin receptor antagonism in the treatment of LPS-induced shock we conducted a randomized study with anaesthetized piglets. Before randomization the animals were stratified according to predetermined health
Autor:
Aparecida S. Tanaka, Norlene R. Bueno, Misako U. Sampaio, Claudio A. M. Sampaio, Hans Fritz, Ennes A. Auerswald, Isabel de Fátima Correia Batista, Maria Luiza Vilela Oliva
Publikováno v:
Immunopharmacology. 32:62-66
The action of two Bowman-Birk and several plant Kunitz-type inhibitors were studied on trypsin, chymotrypsin, plasma kallikrein and factor XII. The primary structure of some of them was completely defined. The results showed that the Bowman-Birk type
Publikováno v:
Europe PubMed Central
The pharmacokinetics and the anticoagulant effects of hirudin were investigated in 12 healthy volunteers after single subcutaneous or intravenous bolus administrations. Hirudin concentrations in citrated plasma and urine were determined with a radioi
Autor:
Matthias Siebeck, Hans Fritz, Marion Weis, Hans Hoffmann, Marianne Jochum, Michael Spannagl, Reinhard Geiger
Publikováno v:
American Review of Respiratory Disease. 142:782-788
We hypothesized that thrombin activation may play a prominent role in endotoxin-induced secondary organ failure, such as acute lung injury. To test this hypothesis, we administered a thrombin-specific inhibitor, recombinant hirudin, in endotoxemic pi